healthWednesday, July 1, 2026
Today brings two major scientific milestones: the first early human eggs derived from stem cells, and a study showing donor-derived CAR T cells with stem-cell memory properties achieve deep responses. Meanwhile, a policy clash over peptide deregulation pits RFK Jr. against FDA scientists.
A landmark in fertility research arrives alongside a sobering report on maternal health in Gaza.
Researchers have turned induced pluripotent stem cells into early-stage human egg cells (oogonia), a first for human reproduction. The work builds on mouse studies and could eventually transform fertility treatment.
Miscarriage rates in Gaza have surged to nearly 50% of pregnancies, up from 14% prewar, driven by malnutrition, contaminated water, and collapsed health services. The number is a stark indicator of the humanitarian crisis.
A first-in-human study shows donor-derived CAR T cells with stem-cell memory traits outperform standard cells.
This first-in-human study of donor-derived CD19-CAR T cells after transplant relapse found that CAR-modified stem-cell memory T cells expanded and persisted far better than standard CAR T cells, enabling complete responses at low doses.
A regulatory battle over peptides and a cultural trend toward extreme thinness after 40 both raise health concerns.
Health Secretary RFK Jr. wants to deregulate several peptides for compounding pharmacy access, but FDA scientists say safety and efficacy data are lacking, some peptides have never been studied in humans. An advisory committee will weigh in soon.
A Brazilian report highlights a return to extreme thinness as a beauty ideal for women over 40, driven by celebrities like Olivia Wilde and Demi Moore. The trend raises risks of muscle loss, osteoporosis, and eating disorders in an age group already vulnerable to metabolic changes.
science roundup
personal roundup
travel roundup
cryptocurrency roundup
art roundup
finance roundup
